Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortical excitability in sleep bruxism before and after botulinum toxin A injection
TCTR20230224002Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in sleep bruxism, sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Cortical silent period. Started Dec 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
sleep bruxism
Beyond the preview
Go deeper on TCTR20230224002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230224002.